2Jemal A. Global cancer stastistics. CA Cancer [J ]. Clin, 2011, 61 (2) : 69-90.
3Arihara F, Mizukoshi E, Kitahara M, et al. Increase in CD14 +HLA-DR-/low myeloid-derive suppressor cells in hepatocellular carcinoma patients and its impact on prognosis [ J ]. Cancer Immunol lmmunother, 2013,62 ( 8 ) : 1421 - 1430.
4Fukuhara T,Aikata H, Hyogo lq, et al. Efficacy of radiofrequency ablation for inital recurrent hepatocelluar carcinoma after curative treatment : Comparison with primary cases [ J ]. Eur J Radiol, 2015,84 ( 8 ) : 1540-1545.
5Ikeda Y, Kajiyama K, Yamashita Y, et al. Differential expression of insulin-like growth factor l in human primary liver cancer [J].Fukuoka lgaku Zasshi, 2013, 104(10) : 334-338.
6Wong VW, Yu J, Cheng AS, ct al. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B [J]. Int J Cancer,2009,124 (12) : 2766-2770.
7Shen Y, Wei Y, Wang Z, et al. TGF-13 regulates hepatocellular carcinoma progession by including Treg cell polarization [J]. Cell Physiol Biochem, 2015,35 (4) : 1623-1632.
8Li T, Zhao S, Song B, et al. Effect of transforming growth factor 13-1 infected human bone marrow mesenchymal stem ceils on high-and-low-metastatic potential hepatocellular carcinoma [J]. Eur J Med Res,2015,20:56.
9Mamiya T, Ymazaki K, Masugi Y, et al. Reduced transforming growth factor-beta recptor 11 expression in hepatocelluar carcinoma correlates with intrahepatic metastasis [J]. Lab Invest,2010,90(9) : 1339-1345.
10Han Y, Chen Z, Yang Y, et al. Human CD14 CTLA-4 regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine- 2,3-dioxygenase production in hepatocelluar carcinoma [J]. Hepatology, 2014,59 (2) : 567-579.
